院士报告为颠覆性技术“把脉问诊”

Group 1: Innovation in Pharmaceuticals - China has made significant progress in innovative drug development, with the number of approved new drugs increasing from 4 in 2015 to 37 in 2024, and the proportion of first-in-class drugs rising from 4% to 38% [1] - Despite the advancements, challenges such as lack of original theories and technologies, intense competition, changing international environments, and payment system issues pose risks to sustainable industry growth [1][2] Group 2: Development of eVTOL Industry - The eVTOL industry in China is rapidly developing, with a competitive landscape and a leading position globally [2] - Key challenges include distributed propulsion aerodynamics, high-energy power sources, and safety control in complex environments, with a focus on smart technology as a solution [2] Group 3: Quantum Computing and Technology - The development of quantum technology is highlighted as a path for differentiation, with a focus on solid-state quantum computing and scientific instrument research [3] - Emphasis on the need for independent research and development of scientific instruments to strengthen China's position in technology [3] Group 4: Brain-Computer Interface Advancements - Brain-computer interfaces are categorized into brain control and brain modulation, with applications in aiding patients with movement disorders and treating mental health conditions [3] - Non-invasive techniques for brain modulation are being explored, which could avoid the side effects associated with traditional invasive surgeries [3] Group 5: Overall Technological Landscape - The reports from the four academicians reflect China's technological self-reliance and the realities of global technological competition, emphasizing the need to confront challenges to maintain leadership in disruptive innovation [4]